Dr. Michael Jain

Dr. Michael Jain

Medical Oncologist
Moffitt Cancer Center

Dr. Michael Jain is an assistant member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. Dr. Jain earned his medical degree at McGill University in Montréal, Canada, and completed both his internal medicine and hematology residencies at the University of Toronto.

Dr. Jain’s clinical focus is on treatments for relapsed lymphoma, particularly stem cell transplantation, cellular therapies, and immunotherapies. His research interests include lymphoma and early-phase clinical trials.

Recurrence

CAR T-Cell Therapy Side Effects Can Be Serious, But Many Are Short-Lived
Recurrence

When Non-Hodgkin Lymphoma Relapses: How Chemotherapy Can Help
Treatment

Lenalidomide (Revlimid): Stimulating Your Immune System to Shrink Your Cancer
Treatment

Why Clinical Trials for Diffuse Large B-Cell Lymphoma Are So Important
Recurrence

CAR T-Cell Therapy: Making Your Body a More Efficient Cancer Fighter
Treatment

You May Have Side Effects Years After Non-Hodgkin Lymphoma Treatment: Here’s What to Watch For
Living With Cancer

Non-Hodgkin Lymphoma Treatment — and Beyond
Recurrence

Treatment After Relapse: Combatting Non-Hodgkin Lymphoma the Second Time Around
Recurrence

What’s the Risk of Relapse After Non-Hodgkin Lymphoma Treatment?
Prevention & Risk

Age, Race, and Exposures Might All Factor Into Lymphoma Risk
Close

SN GUIDES

The First 60

Begin the breast cancer journey with confidence.

SIGN UP NOW

Thank you!

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.